Show simple item record

dc.contributor.authorBramness, Jørgen Gustav
dc.contributor.authorvon Soest, Tilmann
dc.coverage.spatialNorwaynb_NO
dc.date.accessioned2019-12-20T13:50:12Z
dc.date.available2019-12-20T13:50:12Z
dc.date.created2019-06-11T10:30:16Z
dc.date.issued2019
dc.identifier.citationBramness, J. G. and T. von Soest (2019). "A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults." BMC Pulm Med 19(1): 52. doi: 10.1186/s12890-019-0814-xnb_NO
dc.identifier.issn1471-2466
dc.identifier.urihttp://hdl.handle.net/11250/2634330
dc.description.abstractBACKGROUND: A small number of studies have shown that the use of cannabis increases the risk of bronchial asthma. There is, however, a paucity of longitudinal studies which are able to control for known risk factors of bronchial asthma. METHODS: Survey data from a population-based longitudinal study encompassing 2602 young adults followed for 13 years were coupled with individual prescription data on asthma medication (β2-adrenergic receptor agonists and glucocorticoids for inhalation) from the Norwegian national prescription database, which covers the entire Norwegian population. Current cannabis use, gender, age, years of education, body mass index (BMI; kg/m2) and current smoking were measured. RESULTS: Prescription of asthma medication was associated with female gender, self-reported earlier asthma and allergies, daily tobacco smoking and current cannabis use. In a model adjusting for gender, age, years of education, BMI, earlier self-reported asthma and allergies and current tobacco smoking the odds ratio for a current cannabis user to fill prescriptions for asthma medication was 1.71 (95% CI: 1.06-2.77; p = 0.028). CONCLUSIONS: This suggests that cannabis is a risk factor for bronchial asthma or use of asthma medication even when known risk factors are taken into consideration. Intake of cannabis through smoking should be avoided in persons at risk.nb_NO
dc.description.sponsorshipThe data collection was funded by several grants from the Research Council of Norway. The funders had no role in the design of the study and collection, analysis, interpretation of the data, or decision to submit results.nb_NO
dc.language.isoengnb_NO
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectAdolescent; Asthma medication; Cannabis; Longitudinal; Smokingnb_NO
dc.titleA longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adultsnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.rights.holder© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.nb_NO
dc.source.pagenumber1-7nb_NO
dc.source.volume19: 52nb_NO
dc.source.journalBMC Pulmonary Medicinenb_NO
dc.source.issue1nb_NO
dc.identifier.doi10.1186/s12890-019-0814-x
dc.identifier.cristin1703878
cristin.unitcode1991,0,0,0
cristin.unitnameSykehuset Innlandet HF
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal